BriLife
0 sources
BriLife
Summary
BriLife is a funded product[1]. BriLife draws 7 Wikipedia views per month (funded_product category, ranking #9 of 11).[2]
Key Facts
- BriLife's image is recorded as Reuven Rivlin with the first vaccinator in Phase B of the Israeli Vaccine of the Israeli Biological Institute, January 2021 (GPOABG 4045).jpg[3].
- BriLife's instance of is recorded as funded product[4].
- BriLife's manufacturer is recorded as Israel Institute for Biological Research[5].
- BriLife's developer is recorded as Israel Institute for Biological Research[6].
- BriLife's subclass of is recorded as COVID-19 vaccine[7].
- BriLife's subclass of is recorded as viral vector vaccine[8].
- BriLife's subclass of is recorded as vaccine candidate[9].
- BriLife's Commons category is recorded as BriLife[10].
- BriLife's country of origin is recorded as Israel[11].
- BriLife's route of administration is recorded as injection[12].
- BriLife's vaccine for is recorded as COVID-19[13].
- BriLife's Vaccine Ontology ID is recorded as VO_0005090[14].
- BriLife's funder is recorded as Israel[15].
Why It Matters
BriLife draws 7 Wikipedia views per month (funded_product category, ranking #9 of 11).[2] BriLife has Wikipedia articles in 7 language editions, a strong signal of global cultural recognition.[16] BriLife is known by 3 alternative names across languages and contexts.[17]